Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. [electronic resource]
Producer: 20020405Description: 47-58 p. digitalISSN:- 1043-1802
- Acute Disease
- Aminoglycosides
- Animals
- Anti-Bacterial Agents -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antigens, CD -- immunology
- Antigens, Differentiation, Myelomonocytic -- immunology
- Cross-Linking Reagents
- Gemtuzumab
- HL-60 Cells
- Humans
- Immunotoxins -- therapeutic use
- Indicators and Reagents
- Leukemia, Myeloid -- drug therapy
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Sialic Acid Binding Ig-like Lectin 3
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.